US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

243.09

+20.099.01%

Post-market: 242.18-0.9100-0.37%19:59 EDT

Volume:607.60K

Turnover:144.89M

Market Cap:637.99M

PE:- -

High:246.22

Open:223.71

Low:222.45

Close:223.00

52wk High:341.93

52wk Low:102.35

Shares:2.62M

Float Shares:2.62M

Volume Ratio:1.01

T/O Rate:23.15%

Dividend:0.91

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live

Rubicon Research Reports Procedural Observation After Unannounced US FDA Inspection at Satara Plant

Looking for Dividend Aristocrats? These 3 Healthcare Stocks Deserve a Closer Look

Movement Alert｜Direxion Daily S&P Biotech Bull 3x Shares Rises 8.25% in Regular Trading, Leveraged Biotech ETF Rebounds on Oversold Technical Repair

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), United Therapeutics (UTHR) and Ionis Pharmaceuticals (IONS)

Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Veeva Systems (VEEV) and Bristol-Myers Squibb (BMY)

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Tilray (TLRY) and Viatris (VTRS)

Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial

Teva Pharmaceutical Industries Says FDA Approved WELTRUZA for Schizophrenia in Adults

MT Newswires Live

Analysts’ Top Healthcare Picks: Biohaven Ltd. (BHVN), Clover Health Investments (CLOV)

Teva announces FDA approval for Weltruza

Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia

National Healthcare Properties (NHP) Reaffirms Dividend, Is The Stock Still A Bargain?

Simply Wall St.

Health Care Roundup: Market Talk

Humanwell Healthcare Unit Secures US FDA Nod for Angina Drug

MT Newswires Live

Sigma Healthcare Details ESG Strategy in 2026 Sustainability Report

Lupin Gets US FDA Approval for Vitamin K Injection

MT Newswires Live

Linical Wins $20 Million U.S. Biotech Order as FDA Environment Normalizes

Wall Street Analysts Are Bullish on Top Healthcare Picks

Mayne Pharma Group Receives US FDA Confirmation on Fulfillment of Post-Marketing Requirement for Vaginal Inserts

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigerhkgo.com/stock/LABU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":243.09,"timestamp":1791576000000,"preClose":223,"halted":0,"volume":607600,"hourTrading":{"tag":"盘后","latestPrice":242.18,"preClose":243.09,"latestTime":"19:59 EDT","volume":3944,"amount":956626.8862,"timestamp":1791590359878,"change":-0.91,"changeRate":-0.003743,"amplitude":0.004484},"delay":0,"changeRate":0.09008968609865473,"floatShares":2624500,"shares":2624500,"eps":0,"marketStatus":"Not Yet Opened","change":20.09,"latestTime":"10-09 16:00:00 EDT","open":223.71,"high":246.22,"low":222.45,"amount":144887402.828,"amplitude":0.106592,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":223,"sharesOutstanding":3074486,"nav":242.822,"aum":649423578.22,"dividendRate":0.003761,"bidAskSpread":0.002692,"preHourTrading":{"tag":"盘前","latestPrice":223.28,"preClose":223,"latestTime":"09:28 EDT","volume":2212,"amount":498293.87776,"timestamp":1791552512789,"change":0.28,"changeRate":0.001256,"amplitude":0.01487},"postHourTrading":{"tag":"盘后","latestPrice":242.18,"preClose":243.09,"latestTime":"19:59 EDT","volume":3944,"amount":956626.8862,"timestamp":1791590359878,"change":-0.91,"changeRate":-0.003743,"amplitude":0.004484},"volumeRatio":1.0135274892123673,"impliedVol":0.9666,"impliedVolPercentile":0.7052},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2624500,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0135274892123673,"shares":2624500,"dividePrice":0.9143,"high":246.22,"amplitude":0.106592,"preClose":223,"low":222.45,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":243.09,"eps":0,"divideRate":0.003761,"volume":607600,"delay":0,"ttmEps":0,"open":223.71,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":248.72,"twentyDayClose":261.3,"sixtyDayClose":254.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674865017","title":"Exchange-Traded Funds Rise as US Equities Advance After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2674865017","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674865017?lang=en_us&edition=fundamental","pubTime":"2026-10-10 01:15","pubTimestamp":1791566120,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV were higher. Actively traded Invesco QQQ Trust (QQQ) added 0.4%.US equity indexes rose, with consumer discretionary leading the se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GPIQ","BITO","IAUI","IYH","SBIT","YGLD","BTCC","FAZ","ETHT","DEFI","CBOA","HODL","GBTC","VIS","BITU","ETHD","ETQ","BK4593","OUNZ","XBTY","YBTC","VDC","SOXL","TETH","SOXX","ETH.USD.CC","CBTJ","DFII","BETH","NAPR","SCO","XLY","QDEC","ARKB","CBOO","QLD","XLP","BTCZ","BAR","FBTC","BITI","SETH","VHT","BK4547","BK4581","TQQQ","NOCT","GLDM","ETCO","BK4585","FAS","MAXI","XLPD","BTC.USD.CC","IAU","UGL","GLD","SLV","QQQM","XLI","XLK","BGLD","BTF","RTH","SOXS","BCCC","BRRR","KGLD","CBXY","BAGY","BK4534","BK4504","UCO","CBTO","IYW","ETH","BITX","USG","DGZ","NDX","RETL","CBXJ","UNG","XSD","CBOY","QQQ","BETE","ESK","IBIT","BFJL","IYE","USO","XLE","XLF","BTCW","DGP","IBB","CBTA","QID","XLV","BITB","TECL","SIVR","GLDY","XAGUSD.FOREX","CBOJ","GLL","BFAP","XBI","DULL","XRT","SGOL","QQQX","TQQY","BK4588","BK4561","BTRN","EETH","XLPU","BTCL","CBTY","LABU","BTCO","PSQ","SQQQ","XAUUSD.FOREX","QMAR","BITY","IGM","QBF","CBXA","EZBC","IYJ","AAAU","FGDL","NJAN","IAUM","NJUL","BK4550","ZSL","BPI","IGLD","CBXO","BTC","SHNY","AGQ","BK4570","MNRS","DZZ","BTCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674863205","title":"Rubicon Research Reports Procedural Observation After Unannounced US FDA Inspection at Satara Plant","url":"https://stock-news.laohu8.com/highlight/detail?id=2674863205","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674863205?lang=en_us&edition=fundamental","pubTime":"2026-10-09 23:54","pubTimestamp":1791561248,"startTime":"0","endTime":"0","summary":"Rubicon Research Limited ( ($IN:RUBICON) ) has provided an update. Rubicon Research Limited disclosed that the U.S. Food and Drug Administration ca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rubicon-research-reports-procedural-observation-after-unannounced-us-fda-inspection-at-satara-plant?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rubicon-research-reports-procedural-observation-after-unannounced-us-fda-inspection-at-satara-plant?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674850231","title":"Looking for Dividend Aristocrats? These 3 Healthcare Stocks Deserve a Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2674850231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674850231?lang=en_us&edition=fundamental","pubTime":"2026-10-09 22:28","pubTimestamp":1791556084,"startTime":"0","endTime":"0","summary":"AbbVie ($ABBV), Johnson & Johnson ($JNJ), and Medtronic ($MDT) are three healthcare companies with established dividend-growth records and deserve ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/looking-for-dividend-aristocrats-these-3-healthcare-stocks-deserve-a-closer-look?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/looking-for-dividend-aristocrats-these-3-healthcare-stocks-deserve-a-closer-look?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","GDOC","JDOC","XBI","LU0072461881.USD","LU2750360997.AUD","BK4007","LU0912757837.SGD","LU1244550221.USD","LU0058720904.USD","LU0943347566.SGD","IXJ","LU1894683264.USD","IE000SO60NU8.SGD","TRUH","JNJ","LU1066051225.USD","PJP","IYH","CGCV","LU2602419157.SGD","RXL","VHT","LU1496350502.SGD","VIG","LU0795875169.SGD","LU0787776722.HKD","LU1551013342.USD","LU1003077747.HKD","BMED","LU0689626769.HKD","TCAF","LU2471134796.USD","HCSG","IE00B3PB1722.GBP","LU1121112475.USD","FTXH","XLV","LU0964807845.USD","LABU","IHE","NOBL","LU1162221912.USD","LU1929549753.HKD","SG9999013999.USD","LU0545039389.USD","LU0820561818.USD","BK4504","LU1732800096.USD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117122117","title":"Movement Alert｜Direxion Daily S&P Biotech Bull 3x Shares Rises 8.25% in Regular Trading, Leveraged Biotech ETF Rebounds on Oversold Technical Repair","url":"https://stock-news.laohu8.com/highlight/detail?id=1117122117","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117122117?lang=en_us&edition=fundamental","pubTime":"2026-10-09 22:05","pubTimestamp":1791554745,"startTime":"0","endTime":"0","summary":"On October 9, Direxion Daily S&P Biotech Bull 3x Shares rose 8.25% in regular trading, trading at $239.0/share, with Turnover of $39.1446 million. The fund provides triple leveraged exposure to the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Leveraged Biotech ETF Rebounds on Oversold Technical Repair","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674852049","title":"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), United Therapeutics (UTHR) and Ionis Pharmaceuticals (IONS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674852049","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674852049?lang=en_us&edition=fundamental","pubTime":"2026-10-09 21:20","pubTimestamp":1791552051,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Johnson & Johnson (JNJ), United Therapeutics (UTHR) and Ionis Pha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-united-therapeutics-uthr-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-united-therapeutics-uthr-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1162221912.USD","LU2403377893.USD","LU1145028129.USD","LU0053666078.USD","JNJ","LU0689626769.HKD","SG9999002224.SGD","BMED","BK4581","LU1674673691.USD","TRUH","BK4592","LU0072461881.USD","IE00BLSP4239.USD","IE00BVYPNW00.USD","IE00BDGV0183.EUR","MEDX","IE0002141913.USD","JDOC","IHE","RXL","IE00BKVL7J92.USD","FHLC","LABU","IYH","LU0069063385.USD","LU0289961442.SGD","VHT","BK4532","FTXH","LU0882574055.USD","LU2430703178.SGD","LU1989771016.USD","IONS","HCSG","LU1291159041.SGD","PJP","LU0545039389.USD","LU1914381329.SGD","SGXZ80539844.SGD","XLV","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","LU2756315664.SGD","LU1066051225.USD","LU0058720904.USD","XBI","UTHR","GDOC","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674854024","title":"Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Veeva Systems (VEEV) and Bristol-Myers Squibb (BMY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674854024","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674854024?lang=en_us&edition=fundamental","pubTime":"2026-10-09 20:50","pubTimestamp":1791550213,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Henry Schein (HSIC), Veeva Systems (VEEV) and Bristo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-henry-schein-hsic-veeva-systems-veev-and-bristol-myers-squibb-bmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-henry-schein-hsic-veeva-systems-veev-and-bristol-myers-squibb-bmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4559","IE00BFXG1179.USD","LU0058720904.USD","LU1323610961.USD","LU2242646821.SGD","LU1430594728.SGD","LU1883839398.USD","BK4137","LU0225771236.USD","LU1093756325.SGD","HSIC","BK4175","LU0225284248.USD","LU1670711123.USD","LU1868836914.USD","VEEV","IE0002141913.USD","BMY","IE00BJT1NW94.SGD","LU1670710661.SGD","LU1815336091.USD","LU2125154778.USD","LU0868494617.USD","LU1236620834.HKD","LU2360032135.SGD","LU0061475181.USD","FTXH","IE00BSNM7G36.USD","LU1868836591.USD","XLV","XBI","IE0009355771.USD","BK4528","EKG","LGHT","BK4588","LABU","LU0266013472.USD","LU0882574055.USD","LU1585245621.USD","IHE","LU2133065610.SGD","LU1670710588.SGD","LU0170899867.USD","LU0267386448.USD","LU1983299246.USD","LU0096364046.USD","LU0306807586.USD","HCSG","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674851271","title":"Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Tilray (TLRY) and Viatris (VTRS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674851271","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674851271?lang=en_us&edition=fundamental","pubTime":"2026-10-09 20:11","pubTimestamp":1791547873,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on United Therapeutics (UTHR), Tilray (TLRY) and Viatris (VTRS). Uni...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-united-therapeutics-uthr-tilray-tlry-and-viatris-vtrs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-united-therapeutics-uthr-tilray-tlry-and-viatris-vtrs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","LU1839511570.USD","LABU","BK4532","LU2087621335.USD","BK4007","HCSG","LU1571399168.USD","BK4583","BK4137","BK4139","BK4588","VTRS","BK4547","BK4581","XBI","XLV","BK4596","BK4585","UTHR","LU0029874061.USD","TLRY","LU0128526141.USD","LU1699723380.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674851432","title":"Milestone Pharmaceuticals Announces First European Study Participant Enrolled in  ReVeRA-301 Phase 3 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2674851432","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674851432?lang=en_us&edition=fundamental","pubTime":"2026-10-09 20:00","pubTimestamp":1791547200,"startTime":"0","endTime":"0","summary":"Dutch Cardiovascular Investigator Network (WCN) Leads European Enrollment in Phase 3 Study Evaluating Etripamil Nasal Spray for AFib-RVRMONTREALandCHARLOTTE, N.C., Oct.  09, 2026 (GLOBE NEWSWIRE) -- M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/09/3378055/0/en/milestone-pharmaceuticals-announces-first-european-study-participant-enrolled-in-revera-301-phase-3-clinical-trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1721428933.USD","LU0347712357.USD","LU0354030438.USD","LU2413666426.HKD","EPV","LU2413666699.HKD","LU1559883803.SGD","BK4588","LU2463526074.USD","BK4129","LU2298321311.HKD","LU2092937221.SGD","LU2360108059.USD","BK4585","LU0354030511.USD","LABU","LU2041044095.USD","LU0566484027.USD","LU2125910336.SGD","WCN","VR","EVX","AV","LU1923621640.USD","LU2125910179.SGD","BK4120","ECG","LU1892829315.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674859554","title":"Teva Pharmaceutical Industries Says FDA Approved WELTRUZA for Schizophrenia in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2674859554","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674859554?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:36","pubTimestamp":1791545799,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries  said Friday that the US Food and Drug Administration has approved WELTRUZA for extended-release injectable suspension of olanzapine for subcutaneous use as a treatment of schizophrenia in adults.The company said WELTRUZA will be available in the US in the coming weeks in once-monthly subcutaneous injectable doses of 318 mg, 425 mg and 531 mg.The injections will not require loading doses, oral supplementation, or post-injection monitoring, the company said.Teva said approval was based on results from its phase-3 Solaris trial, which showed a significant reduction in illness severity and improvement in personal and social functioning.The company said the treatment's safety profile was consistent with oral olanzapine, while reported adverse events included weight gain, sleepiness, headache, constipation and injection-site reactions.Shares of the company were up 3.4% in Friday's premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4566","BK4584","BK4557","LU2324357040.USD","LABU","BK4585","TEVA","BK4559","BK4596","LU1983299246.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674859625","title":"Analysts’ Top Healthcare Picks: Biohaven Ltd. (BHVN), Clover Health Investments (CLOV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674859625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674859625?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:30","pubTimestamp":1791545420,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biohaven Ltd. (BHVN) and Clover Health Investments (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-biohaven-ltd-bhvn-clover-health-investments-clov-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-biohaven-ltd-bhvn-clover-health-investments-clov-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU1093756168.USD","XLV","LABU","BK4581","CLOV","LU0128526141.USD","BK4139","LU0029874061.USD","BK4585","BK4588","BK4154","HCSG","LU1093756325.SGD","BHVN","XBI","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674785642","title":"Teva announces FDA approval for Weltruza","url":"https://stock-news.laohu8.com/highlight/detail?id=2674785642","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674785642?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:05","pubTimestamp":1791543924,"startTime":"0","endTime":"0","summary":"Teva (TEVA) announced that the FDA has approved Weltruza for extended-release injectable suspension, a new, once-monthly, subcutaneous long-acting ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-for-weltruza-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-for-weltruza-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","LABU","XLVX","GDOC","GNMX","FRTY","BMED","BK4007","IEIH","MRNY","MRNX","BBP","BK4584","LU1983299246.USD","RSPH","IYH","BK4588","BK4559","IBB","LFSC","PINK","SYNB","IDNA","NVIB","TBXU","BK4596","LU2324357040.USD","PSCH","TECB","MEDI","BK4585","BK4566","TEVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674856420","title":"Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2674856420","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674856420?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:00","pubTimestamp":1791543600,"startTime":"0","endTime":"0","summary":"WELTRUZA (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous long-acting injectable (LAI) formulation of olanzapine for the treatment of schizophren","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/09/3378000/0/en/teva-announces-u-s-food-and-drug-administration-fda-approval-of-weltruza-olanzapine-for-extended-release-injectable-suspension-as-the-first-and-only-once-monthly-subcutaneous-injec.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXJ","VHT","BK4588","CGCV","LABU","PSP","TCAF","MAA","BK4081","BK4585","BK4550","NOBL","EMA","SPRE","BK4215","NMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674859193","title":"National Healthcare Properties (NHP) Reaffirms Dividend, Is The Stock Still A Bargain?","url":"https://stock-news.laohu8.com/highlight/detail?id=2674859193","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674859193?lang=en_us&edition=fundamental","pubTime":"2026-10-09 18:45","pubTimestamp":1791542737,"startTime":"0","endTime":"0","summary":"National Healthcare Properties (NHP) just reaffirmed its income focus, with the board declaring a quarterly cash dividend of $0.075 per share. The payout is scheduled for October 16, with an ex dividend date of October 9.\nThe dividend announcement lands after a mixed stretch for National Healthcare Properties, with the share price return down 5.8% over the past week and 7.9% over the past month, yet still up 26.6% year to date. This suggests that longer term momentum remains intact even as...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9621071-choice2-card/1788985081922","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9621071-choice2-card/1788985081922"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nasdaq-nhp/national-healthcare-properties/news/national-healthcare-properties-nhp-reaffirms-dividend-is-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nasdaq-nhp/national-healthcare-properties/news/national-healthcare-properties-nhp-reaffirms-dividend-is-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XBI","BK4585","VIG","BK4581","XLV","BK4225","LABU","NHP","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674730834","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2674730834","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674730834?lang=en_us&edition=fundamental","pubTime":"2026-10-09 16:20","pubTimestamp":1791534000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0530 GMT - Terumo's exit from its plasma collection business is ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4581","XLV","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674836433","title":"Humanwell Healthcare Unit Secures US FDA Nod for Angina Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2674836433","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674836433?lang=en_us&edition=fundamental","pubTime":"2026-10-09 14:45","pubTimestamp":1791528323,"startTime":"0","endTime":"0","summary":"Humanwell Healthcare's (SHA:600079) 80% owned subsidiary Yichang Humanwell Pharmaceutical has received approval from the US Food and Drug Administration for its Abbreviated New Drug Application for di","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["600079","LU0128526141.USD","XBI","BK4588","XLV","BK0239","BK0185","LABU","BK0070","BK0188","LU0029874061.USD","BK4137","BK4581","HCSG","BK0028","BK0096","BK4585","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674280835","title":"Sigma Healthcare Details ESG Strategy in 2026 Sustainability Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2674280835","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674280835?lang=en_us&edition=fundamental","pubTime":"2026-10-09 14:14","pubTimestamp":1791526470,"startTime":"0","endTime":"0","summary":"Sigma Healthcare Ltd ( ($AU:SIG) ) has shared an announcement. Sigma Healthcare has released its 2026 Sustainability Report, outlining how it manag...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-details-esg-strategy-in-2026-sustainability-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-details-esg-strategy-in-2026-sustainability-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","XBI","LU0029874061.USD","BK4137","BK4581","BK4585","PRXI","BK4588","LABU","IVRA","LU0128526141.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674887430","title":"Lupin Gets US FDA Approval for Vitamin K Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2674887430","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674887430?lang=en_us&edition=fundamental","pubTime":"2026-10-09 11:21","pubTimestamp":1791516097,"startTime":"0","endTime":"0","summary":"Lupin  received U.S. Food and Drug Administration approval for its Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL single-dose prefilled syringe, according to a Thursday exchange filing.The product is bioequivalent to International Medication Systems' reference drug and is indicated for treating and preventing low blood clotting and vitamin K deficiency, the filing said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674184887","title":"Linical Wins $20 Million U.S. Biotech Order as FDA Environment Normalizes","url":"https://stock-news.laohu8.com/highlight/detail?id=2674184887","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674184887?lang=en_us&edition=fundamental","pubTime":"2026-10-09 10:52","pubTimestamp":1791514334,"startTime":"0","endTime":"0","summary":"Linical Co., Ltd. ( ($JP:2183) ) has issued an update. Linical Co., Ltd. has secured a large new order from a U.S. biotechnology company worth 20.4...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/linical-wins-20-million-u-s-biotech-order-as-fda-environment-normalizes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/linical-wins-20-million-u-s-biotech-order-as-fda-environment-normalizes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XBI","JDOC","AGNG","IEIH","PBE","BK4588","BK4581","FWD","FHLC","LNGR","BBP","IBB","XBIX","LABU","SYNB","XT","RSPH","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674823408","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2674823408","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674823408?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:50","pubTimestamp":1791510620,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CSL (CMXHF), Ionis Pharmaceuticals (IONS) and Cormed...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-375?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-375?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IONS","BK4588","BK4581","BK4585","BK4137","HCSG","BK4139","CMXHF","LU0029874061.USD","XBI","XLV","LU0128526141.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674886132","title":"Mayne Pharma Group Receives US FDA Confirmation on Fulfillment of Post-Marketing Requirement for Vaginal Inserts","url":"https://stock-news.laohu8.com/highlight/detail?id=2674886132","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674886132?lang=en_us&edition=fundamental","pubTime":"2026-10-09 08:05","pubTimestamp":1791504310,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  received a letter from the US Food and Drug Administration  confirming the company's fulfillment of its post-marketing requirement safety study for IMVEXXY vaginal inserts, according to a Friday filing with the Australian bourse.IMVEXXY is approved by the FDA for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause, the filing said.The study showed that there's no link between very-low-dose vaginal estrogen products and endometrial cancer risk in postmenopausal women, per the filing.Shares fell 2% in morning trade Friday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","MYX.AU","BK4585","LABU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":2,"totalSize":417,"code":"91000000","status":"200"}]}}